Logotype for Tilray Brands Inc

Tilray Brands (TLRY) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Tilray Brands Inc

Q1 2026 earnings summary

22 Dec, 2025

Executive summary

  • Achieved record Q1 net revenue of $210 million, up 5% year-over-year, with net income of $1.5 million and EPS of zero, marking a return to profitability from a prior year net loss of $34.7 million.

  • Adjusted EBITDA rose 9% year-over-year to $10.2 million, supported by organic growth, cost-saving initiatives, and Project 420, which delivered $25.1 million in cumulative savings.

  • Revenue growth was driven by strong performance in Canadian adult-use and international cannabis, as well as distribution and wellness, while beverage revenue remained flat due to SKU optimization.

  • Strengthened balance sheet by reducing outstanding debt by $7.7 million, ending the quarter with $265 million in cash and a net debt-to-EBITDA ratio of 0.07x.

  • Maintained leadership in Canadian cannabis, expanded international presence, and continued innovation in beverage and wellness segments.

Financial highlights

  • Net revenue reached $210 million, a 5% increase year-over-year.

  • Cannabis revenue grew 5% to $64.5 million, with 12% growth in adult-use and 10% in international cannabis.

  • Distribution revenue increased 9% to $74 million, while wellness revenue rose 3% to $15.2 million.

  • Gross profit was $57.5 million (gross margin 27%), down from $59.7 million (30%) last year, due to lower margins in beverage and cannabis.

  • Adjusted EBITDA improved to $10.2 million from $9.3 million last year.

Outlook and guidance

  • Reaffirmed fiscal 2026 guidance for adjusted EBITDA between $62 and $72 million.

  • Expects continued growth in international cannabis as permit backlogs clear and regulatory reforms progress.

  • Anticipates further margin improvements and operational efficiencies in beverage and cannabis segments.

  • Management remains confident in long-term growth, citing opportunities in U.S. cannabis rescheduling and European market evolution.

  • Further realization of Project 420 synergies and ongoing investments in marketing and infrastructure for acquired brands expected.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more